Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Authors
Keywords
-
Journal
Infection and Drug Resistance
Volume Volume 14, Issue -, Pages 3459-3476
Publisher
Informa UK Limited
Online
2021-08-31
DOI
10.2147/idr.s315727
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
- (2021) Tom Shimabukuro et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunological characteristics govern the transition of COVID-19 to endemicity
- (2021) Jennie S. Lavine et al. SCIENCE
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Sputnik V COVID-19 vaccine candidate appears safe and effective
- (2021) Ian Jones et al. LANCET
- Next-generation COVID-19 vaccines: here come the proteins
- (2021) Anna K Blakney et al. LANCET
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021
- (2021) A. Patricia Wodi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
- (2021) Zhenyu He et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada
- (2021) Thomas N. Vilches et al. VACCINE
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
- (2021) Alejandro Jara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
- (2021) Venkata-Viswanadh Edara et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
- (2021) Pinja Jalkanen et al. Nature Communications
- Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
- (2021) Han W. Kim et al. JAMA Cardiology
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Editorial: Development of Humanized Mouse Models for Infectious Diseases and Cancer
- (2020) Moriya Tsuji et al. Frontiers in Immunology
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Covid‐19: Time for a paradigm change
- (2020) Franco M. Buonaguro et al. REVIEWS IN MEDICAL VIROLOGY
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- Engineering Antiviral Vaccines
- (2020) Xingwu Zhou et al. ACS Nano
- Evolution of the COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The lightning-fast quest for COVID vaccines — and what it means for other diseases
- (2020) Philip Ball NATURE
- DNA vaccines against COVID-19: Perspectives and challenges
- (2020) Marcelle Moura Silveira et al. LIFE SCIENCES
- Vaccine-associated hypersensitivity
- (2018) Michael M. McNeil et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search